SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $10.86 million as of 2023-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2025-03-17
- 2023-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $10.86M.
- 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $41.17M.
- 2023-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $76.27M.
- 2023-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $127.15M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2023-12-31 | $10.86M 10-K · filed 2025-03-17 |
| 2023-09-30 | $41.17M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $76.27M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $127.15M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $177.19M 10-K · filed 2024-03-13 |
| 2021-12-31 | $197.68M 10-K · filed 2023-02-23 |
| 2020-12-31 | $510.09M 10-K · filed 2022-02-24 |
| 2019-12-31 | $282.05M 10-K · filed 2021-02-24 |
| 2018-12-31 | $259.71M 10-K · filed 2020-02-28 |